Difficulty: Medium
Average Score: 76%
Practice
Phil is a 54-year-old male with multiple risk factors who has been on a high-dose statin for 3 months to treat his high LDL level. His LDL is 135 mg/dL and his triglycerides are elevated. A reasonable change in therapy would be:
Correct answer
C
Rationale
Phil (LDL 135, high triglycerides, risk factors) benefits from continuing his statin (30-50% LDL drop, 4S) and adding ezetimibe, which cuts LDL another 15-20% (IMPROVE-IT trial) by inhibiting cholesterol absorption. Stopping statins for fibric acids loses LDL control fibric acids target triglycerides. Switching to ezetimibe alone is weaker (20% vs. 50%). Referral is premature combination therapy is standard (ACC/AHA). Adding ezetimibe, per evidence, makes C the rational step.